Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus

Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus

BackgroundSitagliptin is a highly selective dipeptidyl peptide-4 (DPP-4) inhibitor that increases blood levels of active glucagon-like peptide (GLP)-1 and glucose-dependent insulinotrophic polypeptide (GIP), resulting in increased insulin secretion. While studies conducted in other countries have in...

Full description

Bibliographic Details
Main Authors: Soon Ae Kim, Woo Ho Shim, Eun Hae Lee, Young Mi Lee, Sun Hee Beom, Eun Sook Kim, Jeong Seon Yoo, Ji Sun Nam, Min Ho Cho, Jong Suk Park, Chul Woo Ahn, Kyung Rae Kim
Format: Article
Language:English
Published: Korean Diabetes Association 2011-04-01
Series:Diabetes & Metabolism Journal
Subjects:
Diabetes mellitus, type 2
Dipeptidyl peptide-4 inhibitor
Sitagliptin
Online Access:http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-35-159.pdf

Internet

http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-35-159.pdf

Similar Items